Novo Ventures Leads US$55M Series B Investment in NodThera

Novo Ventures Leads US$55M Series B Investment in NodThera

Novo Ventures, part of Novo Holdings, today announced that it has led the $55 million (£44 million) Series B financing in NodThera, a UK and US based clinical stage biotechnology company developing a new class of medicines to treat diseases driven by chronic...